Obstacles and innovations of macrocyclic drug development
Drug Target Review
JANUARY 16, 2025
She has a PhD in Microbiology and Cell Biology from the University of Illinois, followed by work in biochemistry as a post-doctoral fellow at UCSF. About the authors Ann E Cleves Ann is VP of Application Science for Optibrium s BioPharmics Division, which focuses on 3D computational modelling for molecular design.
52 
Let's personalize your content